Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
DB.V
HOLDREMOVEDecibel Cannabis Company Inc. · Healthcare · Canada · $50M · Avg Vol: $19K/d
Decibel Cannabis Company is a micro-cap Canadian cannabis producer. It operates in a structurally broken, highly regulated industry with zero pricing power and persistent capital destruction.
COMPANY DESCRIPTION
Decibel Cannabis Company Inc. is a consumer-focused cannabis producer and brand house operating premium cultivation and processing facilities in Canada. The company commands a leading market share in the high-margin concentrates, vape, and craft flower segments through its popular General Admission and Qwest brands. It distinguishes itself as a vertically integrated operator with a proven track record of brand equity and product innovation in a highly competitive market.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 56.0M | 75.0M | 65.3M | 79.6M | 12.4% |
| EPS | -0.01 | -0.00 | 0.01 | -0.01 | — |
| Shares | 404.7M | 409.0M | 576.7M | 576.9M | +42.6% |
| Debt | 34.2M | 34.2M | 34.1M | 31.2M | -3.0% |
| Equity | 33.3M | 32.6M | 45.7M | 44.0M | 9.7% |
| Op CF | 5.8M | 4.6M | 2.8M | 5.3M | -3.3% |
| Inv CF | -2.7M | -1.5M | 0.8M | -1.4M | — |
| Fin CF | -2.4M | -2.8M | -1.2M | -3.5M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of DB.V are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| DB.V | Decibel Cannabis Company Inc.(you) | $50M | 60 | HOLD |
| HLS.TO | HLS Therapeutics Inc. | $100M | 63 | HOLD |
| LEEF.CN | Leef Brands Inc. | $46M | 29 | SELL |
| NVRS.CN | Noveris Health Sciences Inc. | $64M | 23 | SELL |
| OGI.TO | Organigram Global Inc. | $138M | 33 | SELL |
| RX.V | BioSyent Inc. | $112M | 96 | STRONG BUY |
| ACB | Aurora Cannabis Inc. | $181M | 30 | SELL |
| CRDL.TO | Cardiol Therapeutics Inc. | $123M | 22 | SELL |
| CRON.TO | Cronos Group Inc. | $994M | 62 | HOLD |
| OPTI.CN | Optimi Health Corp. | $25M | 2 | STRONG SELL |
Peer medians: ROE -46.6% · P/E 14.3x · Gross margin 32.9%